CN1547965A - Tea beverage and its prepn - Google Patents
Tea beverage and its prepn Download PDFInfo
- Publication number
- CN1547965A CN1547965A CNA031285449A CN03128544A CN1547965A CN 1547965 A CN1547965 A CN 1547965A CN A031285449 A CNA031285449 A CN A031285449A CN 03128544 A CN03128544 A CN 03128544A CN 1547965 A CN1547965 A CN 1547965A
- Authority
- CN
- China
- Prior art keywords
- tea
- water
- drinking product
- vinegar
- chrysanthemum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Non-Alcoholic Beverages (AREA)
Abstract
The present invention is tea beverage comprising green tea, American ginseng, longan, wolfberry fruit, orange peel, chrysanthemum, cassia seed, vinegar, water, honey, sweetener and carbonic acid gas. The preparation process includes diluting vinegar with water, adding decoction of green tea, American ginseng, longan, wolfberry fruit, orange peel, chrysanthemum and cassia seed, adding honey, sweetener and carbonic acid gas, mixing homogeneously, filtering, packing, and sterilizing. The present invention has the function of raising immunity and is delicious.
Description
Technical field
The present invention relates to a kind of tea-drinking product and preparation method thereof, relate in particular to seed ginseng tea-drinking product and preparation method thereof.
Background technology
Along with the change gradually of consumers in general's dietary structure, people have broken through the demand that tradition is drunk tea, and develop into and drink the health tea material with many-sided health-care effect, have started the able-bodied new way of health care.But tea in the market and health products mostly are the health tea material that common bubble closes drink, and health is poor, the taste that has is not good, and especially also there is the impotable shortcoming of digestive discomfort person in green tea, and reason is that green tea belongs to cold, drink summer, so that people's feeling cool, the person that suffers from the gastric and duodenal ulcer should not drink strong tea, because stimulation is too big, easily causes and has a stomach upset.Thereby tea and health products steep the product of drinking tea that close altogether, can not give full play to the health care of its tea-drinking product.
Summary of the invention
The purpose of this invention is to provide a kind of tea-drinking product and preparation method thereof, seed ginseng tea-drinking product and preparation method thereof especially are provided, it is poor to have overcome present tea-drinking product health, and taste is not good, the shortcoming that digestive discomfort person should not often drink.
The objective of the invention is to be achieved through the following technical solutions:
A kind of tea-drinking product comprise following component: green tea, American Ginseng, dried longan pulp, matrimony vine, orange peel, chrysanthemum, cassia seed, vinegar, water, honey, sweetener, carbonic acid gas.
Described tea-drinking product, preferred following parts by weight of component: green tea 0.8-1.2, American Ginseng 0.01-0.03, dried longan pulp 0.3-0.7, matrimony vine 0.3-0.7, orange peel 0.3-0.7, chrysanthemum 0.3-0.7, cassia seed 0.3-0.7, vinegar and water are in (0.8-1.2): (4-6) ratio is made into 100, honey is an amount of, sweetener is an amount of, carbonic acid gas is an amount of.
Described tea-drinking product, most preferably following parts by weight of component: green tea 1, American Ginseng 0.02, dried longan pulp 0.5, matrimony vine 0.5, orange peel 0.5, chrysanthemum 0.5, cassia seed 0.5, vinegar and water in 1: 5 ratio be made into 100, honey is an amount of, sweetener is an amount of, carbonic acid gas is an amount of.
The preparation method of described tea-drinking product may further comprise the steps:
Get the green tea boiling once, adding American Ginseng, dried longan pulp, matrimony vine, orange peel, chrysanthemum, cassia seed decoct three times again, and decoction liquor is filtered; After the vinegar water diluted in proportion, add above-mentioned filtered fluid, add honey, sweetener and carbonic acid gas again, mixing filters, and is canned, sterilization, promptly.
Decoct green tea the described first time and the water ratio can be 1: 5, described back decoct for three times adds components and the water ratio can be 1: 3.
Described sterilization can be 100 ℃ of steam sterilizations or ultraviolet sterilization.
Described decoction can be after earlier warm fire boils, and vigorous fire decocted 15-30 minute again, preferably decocted 20 minutes.
Described vinegar can be low vinegar, and described water is preferably pure water.
The ginseng tea-drinking product that provided among the present invention, wherein each component has good health properties, and has good coordinative role between the each component.American Ginseng is divided into tonics, has health-care effects such as anti-ageing person, antifatigue, happy intelligence development; Matrimony vine is a yin-nourishing drug, the energy nourishing the liver and kidney; Orange peel is a qi-regulating drug, the warm stomach invigorating the spleen of energy, regulating qi-flowing for eliminating phlegm; Chrysanthemum induces sweat for the medicine that induces sweat, heat radiation, clears liver and improve vision, and detoxication is arranged, and controls headache, and is dizzy, hot eyes, and the ambition dysphoria with smothery sensation is treated sore, pyogenic infections; Cassia seed is an antipyretic, and energy clearing liver, kidney-nourishing make eye bright.
The tea and the fruit of Chinese wolfberry close drink.Not only clothes are very effective for a long time to having a dizzy spell due to the deficiency of liver-yin and kidney-yin, hypopsia, soreness and weakness of waist and knees, seminal emission etc., and high fat of blood, hypertension, artery sclerosis, diabetes etc. are also had certain auxiliary curative effect.
Tea and American Ginseng sheet close drink.Utilize American Ginseng tonifying yin virtual work can and the sweet hot cool character of flavor, adjust tea flavour and make American ginseng tea, the effect of have good beneficial lung nourishing the stomach, enriching yin Tianjin, the clear fire of deficiency type, removing low-heat.
Tea and orange peel drink.Regulate the flow of vital energy, reduce phlegm and internal heat and separate phlegm, antibiotic clear inflammation in can be wide.It is useful that the cough ant phlegm person drinks.
Vinegar, flavor acid, warm in nature, nontoxic, manage all medicines, the detumescence pain.
The present invention has the following advantages:
1, to digestive discomfort person's long-term drinking in right amount;
2, because the component that is added in this ginseng tea-drinking product can significantly improve the anti-energy of human body, increase human body, improve body's immunity sick resistance.
3, component of the present invention is a natural plant, has no side effect.
4, add the auxiliary material flavouring, make this product mouthfeel good.
Toxicity safety evaluatio of the present invention:
One, phase I test
The present invention has been carried out the oral acute toxicity (LD of mouse
50) mensuration.
1, animal Kunming outbreeding system mouse (male and female half and half) is 40, and body weight 180-220g is provided by institute of oncology, Anhui Experimental Animal Center.Animal Lab. is 24 ± 1 ℃ of constant temperature, and relative humidity is 50-70%, and artificial light (time phase: 12 hours bright, and 12 hours dark) divides cylinder to raise, and 5 in every cylinder is fed with common mouse piece material, freely drinks water.
2, experimental technique
Sample is a concentrate of the present invention, and every ml is equivalent to the former medicine of 19ml the present invention, and is as follows.
Mouse is pressed the horn method Random assignment, establishes four groups, and 10 every group, male and female half and half, each is organized dosage and is respectively 10580mg/kg, 5010mg/kg, 2140mg/kg, 1000mg/kg.Took preceding jejunitas 14 hours, drinking-water is not limit.According to dosage once irritate stomach and give clothes, per 10 gram body weight are irritated stomach 0.3ml, give clothes back 2 hours feedings, observe 14 days.Performance and death condition that every day, the observed and recorded animal poisoned.Dead animal performs an autopsy on sb, and weighs once in per 7 days.
Mouse is pressed the horn method Random assignment, establishes four groups, and 10 every group, male and female half and half, each is organized dosage and is respectively 22000mg/kg, 10580mg/kg, 5010mg/kg, 2140mg/kg gives the clothes method the same.
3, computational methods
Calculate following parameters, animal half lethal dose (LD with simplifying probit's general formula
50).
4, experimental result
The present invention is to the oral LD of mouse
50＞10580mg/kg, true border innocuous substance, the LD of male and female mouse
50No significant difference (table 1).
Table 1 the present invention is to chmice acute toxicity (LD
50) measurement result
Dosage number of animals (only) death toll (only)
(mg/kg) male male and female are female
1000 5 5 0 0
2140 5 5 0 0
5010 5 5 0 0
10580 5 5 0 0
The present invention is to chmice acute toxicity (LD
50) measurement result
Dosage number of animals (only) death toll (only)
(mg/kg) male male and female are female
2140 5 5 0 0
5010 5 5 0 0
10580 5 5 0 0
22000 5 5 0 0
5, judge: can carry out the second stage test
Two, second stage test
In view of this product rat oral LD50＞10580mg/kg, the cumulative toxicity experiment in the second stage is omitted, and does following three mutagenicity tests in accordance with regulations.
(1) Salmonella reversion test
1, test method: by the unified approach test of domestic regulation.Treated before the sample test.
2, bacterial classification: by the salmonella typhimurium strain of California, USA university Ames Lab introduction, TA98, TA100, TA97, TA102 four strains through five CHARACTERISTICS IDENTIFICATION, show that enzymatic activity is good recently.
3, S-9 liver particle enzyme is prepared recently by this chamber, through identifying with known mutagen, shows that enzymatic activity is good.
4, dosage and contrast:, done following various dose test simultaneously, various triplicates by above-mentioned condition and method.Employing standard plate mixes method, and each plate adds and tried thing 0.1ml.
1. 1mg/ ware of the present invention
2. 2.5mg/ ware of the present invention
3. 5mg/ ware of the present invention
4. 10mg/ ware of the present invention
Negative control: do not add S-9 activation system mitomycin 0.5 μ g/10 μ l,
Positive control: add S-9 activation system sodium azide 5 μ g/10 μ l.
5, calculate returning of growing on the culture medium and become bacterium colony
The results are shown in Table 2
Table 2 Salmonella reversion test result of the present invention
The every flat board of sample title and dosage returns the change clump count
(μg/m) TA96 TA100 TA97 TA102
-S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Become 27 36 14 165 126 108 216 222 from beaming back
The present invention 25 32 137 158 120 115 196 212
1000
The present invention 28 33 140 158 126 113 190 208
2140
The present invention 27 30 148 157 122 121 188 208
5010
The present invention 23 34 140 163 115 114 201 204
10580
Negative control 26 38 147 148 116 113 201 206
Positive control＞2000＞2000＞2000＞2000＞2000＞2000＞2000＞2000
Result of the test as seen, under each experimental concentration, each ware returns and becomes bacterium bacterium colony number average end and surpass from 2 times that beam back parameter, and each positive controls has shown strong mutagenesis.
According to Salmonella reversion test criterion as a result, think that this is tested under the dosage of every ware 10580ug/ ware, show to cause unexpected change positive effect.
Conclusion:
The present invention of this test is not the mutagenesis positive effect.
(2) PCEMNR micronucleus test
1, method
(1) sample: the same
(2) animal
By the Kunming kind healthy mice that the institute of oncology, Anhui Province provides, totally 50 of male and female, body weight 240-260 gram; Be divided into into five groups, 10 every group, male and female half and half.
(3) dosage grouping and method:
I organizes negative control group (distilled water), V organizes positive controls (endoxan 50mg/kg), other experimental group is respectively II group 1300mg/kg, III organizes 2610mg/kg, this sample of IV group 5010mg/kg, press the 0.1ml/10g capacity and irritate stomach, adopt and give instructions about how to take medicine twice, obeying twice blanking time is 24 hours, last gives clothes after 6 hours, and the mouse cervical vertebra takes off white execution, takes out the both sides femur, with calf serum flushing ossis content, through centrifugal, smear, fixing, dyeing, the cell aberration rate of micronucleus occurs in 1000 polychromatic erythrocytes of every mouse microscopy counting and represent with permillage.
2 results
The test of mouse Bone marrow cells micronucleus: the results are shown in Table 3, by table 3 as seen, give and mouse 1300,2610, the present invention of 5010mg/kg body weight, male mice marrow polychromatic erythrocyte micronuclear rates is respectively 1.2 ‰, 1.4 ‰ ‰, 1.6 ‰; The female mice micronuclear rates is respectively 1.2 ‰, 1.4 ‰.1.4 ‰ with negative control group (distilled water) micronuclear rates, male mice is 1.0%, female mice is 1.0%, learn by statistics and handle P＞0.05, there was no significant difference, positive controls (endoxan) micronuclear rates male mice is 18.8%, female mice is 25.2%, learn by statistics and handle relatively, there is significant difference P＜0.05.Result of the test shows that the present invention finds no tangible mutagenesis to the PCEMNR micronucleus test.
Table 3 PCEMNR micronucleus of the present invention detects
It is male female that dosage number of animals (only) is observed the polychromatic erythrocyte number
Mg/kg hero female (individual/group) contains the micronucleated cell micronuclear rates and contains the micronucleated cell micronuclear rates
Male female born of the same parents' number (‰) born of the same parents' numbers (‰)
0 5 5 5000 5000 5 1.0 5 1.0
1300 5 5 5000 5000 6 1.2 6 1.2
2610 5 5 5000 5000 7 1.4 7 1.4
5010 5 5 5000 5000 8 1.6 7 1.4
Endoxan 55 5,000 5,000 108 21.6 13.3 26.6
Conclusion:
Can think that the present invention does not have influence to the mouse Bone marrow cells micronucleus occurrence rate.
(3) mouse testis chromosome aberration analysis
1, method:
(1) sample: the same
(2) animal
Be the Kunming mouse that the institute of oncology, Anhui Province provides, male 25, body weight 320-350 gram.
(3) dosage grouping and method
Distinguish component at random by body weight and become 5 groups, I organizes negative control group (distilled water), and II organizes 1300mg/kg, and III organizes 2610mg/kg, IV group 5010mg/kg the present invention, and V organizes positive control group (endoxan 50mg/kg).Mouse is pressed the 0.2mL/10g body weight and irritates stomach, once a day, continuous 5 days, observe 100 in counting first metaphase cell, record statistics distortion cell number is calculated aberration rate.
Table 4 mouse testis chromosome aberration assay test result
Dosage number of animals analysis of cells univalent part
Mg/kg (only) number (individual) autosome aberration rate heterosomal aberration rate quantity aberration rate
％ ％ ％
I0 5 500 6 1.2 14 2.8 0 0
II1300 5 500 7 1.4 16 3.2 1 0.2
III2610 5 500 7 1.4 18 3.6 1 0.2
IV5000 5 500 8 1.6 16 3.2 1 0.2
V endoxan 5 500 34 6.8 76 15.2 36 7.2*
50
*P＜0.01
Positive controls is compared with negative control group and each test group as seen from the table all has significant differences (P＜0.01), and the aberration rate of each group of negative control group and the present invention is all in range of normal value.
Conclusion:
The present invention does not show the damaging effect to reproduction cell in the mouse testis chromosome aberration assay test.
Three, to the comprehensive conclusion of first and second step-by-step test of this product security toxicological evaluation
1, the mouse of sample of the present invention, its mouse oral LD50＞100g/kg, true border innocuous substance.
2, the Ames of sample of the present invention experiment, PCEMNR micronucleus test, three mutagenicity tests of mouse testis chromosome aberration assay test, all negative, the same with contrast distilled water, show that sample does not have mutagenicity.
Comprehensive above each point thinks that the present invention does not have toxic and side effect.
The specific embodiment
Embodiment 1
Take by weighing following component, weight (kilogram):
Green tea 1, American Ginseng 0.015, dried longan pulp 0.5, matrimony vine 0.5, orange peel 0.5, chrysanthemum 0.5, cassia seed 0.5, vinegar and water by be made into 100 at 1: 5, honey 0.1, sweetener 0.1, carbonic acid gas 0.005.
The preparation method: get the green tea boiling, warm fire boils earlier, and vigorous fire decocted 20 minutes again; Adding American Ginseng, dried longan pulp, matrimony vine, orange peel, chrysanthemum, cassia seed decoct three times again, and decoction is the same; Decoction liquor is filtered; With the vinegar water dilute in proportion be made into double centner after, add above-mentioned filtered fluid, add honey, sweetener and carbonic acid gas again, mixing filters, filtered fluid, canned 100 ℃ of steam sterilizations, promptly.
Embodiment 2
Take by weighing following component, unit of weight is a kilogram:
Green tea 0.8, American Ginseng 0.02, dried longan pulp 0.3, matrimony vine 0.3, orange peel 0.3, chrysanthemum 0.3, cassia seed 0.3, vinegar and water by be made into 100 at 0.8: 5, honey 0.05, sweetener 0.05, carbonic acid gas 0.002.
The preparation method: with embodiment 1, difference is that the vigorous fire decocting time is 15 minutes.
Embodiment 3
Take by weighing following component, unit of weight is a kilogram:
Green tea 1.2, American Ginseng 0.01, dried longan pulp 0.7, matrimony vine 0.7, orange peel 0.7, chrysanthemum 0.7, cassia seed 1.2, vinegar and water by be made into 100 at 0.8: 6, honey 0.5, sweetener 0.5, carbonic acid gas 0.006.
The preparation method: with embodiment 1, difference is that decocting time is 30 minutes.
Claims (8)
1, a kind of tea-drinking product comprise following component: green tea, American Ginseng, dried longan pulp, matrimony vine, orange peel, chrysanthemum, cassia seed, vinegar, water, honey, sweetener, carbonic acid gas.
2, tea-drinking product according to claim 1 comprise following parts by weight of component: green tea 0.8-1.2, American Ginseng 0.01-0.03, dried longan pulp 0.3-0.7, matrimony vine 0.3-0.7, orange peel 0.3-0.7, chrysanthemum 0.3-0.7, cassia seed 0.3-0.7, vinegar and water are in (0.8-1.2): (4-6) ratio is made into 100, honey is an amount of, sweetener is an amount of, carbonic acid gas is an amount of.
3, tea-drinking product according to claim 1 comprise following parts by weight of component: green tea 1, American Ginseng 0.02, dried longan pulp 0.5, matrimony vine 0.5, orange peel 0.5, chrysanthemum 0.5, cassia seed 0.5, vinegar and water in 1: 5 ratio be made into 100, honey is an amount of, sweetener is an amount of, carbonic acid gas is an amount of.
4, the preparation method of the described tea-drinking product of one of claim 1-3 may further comprise the steps:
Get the green tea boiling once, adding American Ginseng, dried longan pulp, matrimony vine, orange peel, chrysanthemum, cassia seed decoct three times again, and decoction liquor is filtered; After the vinegar water diluted in proportion, add above-mentioned filtered fluid, add honey, sweetener and carbonic acid gas again, mixing filters, and is canned, sterilization, promptly.
5, the preparation method of tea-drinking product according to claim 4, decocting green tea and water ratio the described first time is 1: 5, described back three decoctions add component and the water ratio is 1: 3.
6, the preparation method of tea-drinking product according to claim 4, described sterilization is 100 ℃ of steam sterilizations or ultraviolet sterilization.
7, the preparation method of tea-drinking product according to claim 1, described decoction is for after warm fire boils earlier, and vigorous fire decocted 15-30 minute again.
8, the preparation method of tea-drinking product according to claim 1, it is 20 minutes that described vigorous fire decocts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031285449A CN1547965A (en) | 2003-05-08 | 2003-05-08 | Tea beverage and its prepn |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031285449A CN1547965A (en) | 2003-05-08 | 2003-05-08 | Tea beverage and its prepn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1547965A true CN1547965A (en) | 2004-11-24 |
Family
ID=34322174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031285449A Pending CN1547965A (en) | 2003-05-08 | 2003-05-08 | Tea beverage and its prepn |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1547965A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1921929A4 (en) * | 2005-08-12 | 2009-08-05 | Multi Formulations Ltd | Supplemental dietary composition including caffeine, taurine and ginseng |
| CN101095551B (en) * | 2007-07-19 | 2010-12-01 | 钟旭 | Method for preparing health-care carbonic acid beverage |
| CN101653184B (en) * | 2009-08-25 | 2012-02-22 | 广州市凯虹香精香料有限公司 | Acid inflatable cool-tea drink |
| CN102885149A (en) * | 2012-10-30 | 2013-01-23 | 陈志冲 | Health-care milk tea and preparation method thereof |
| CN103518878A (en) * | 2013-09-26 | 2014-01-22 | 朱奕 | Honey vinegar beverage with function of lubricating intestines and invigorating stomach and preparation method thereof |
| CN104171156A (en) * | 2014-08-25 | 2014-12-03 | 黄家亨 | Rice vinegar tea beverage capable of clearing away heat and toxic materials and preparation method thereof |
| CN104522804A (en) * | 2014-12-22 | 2015-04-22 | 广西南宁桂知科技有限公司 | Chrysanthemum tea vinegar beverage and preparation method thereof |
| CN105707595A (en) * | 2016-02-02 | 2016-06-29 | 田家丰 | Beverage capable of preventing and treating computer xeroma and preparation method of beverage |
| CN105876558A (en) * | 2016-06-25 | 2016-08-24 | 张阳康 | Healthcare beverage and production process thereof |
| CN108813001A (en) * | 2018-05-25 | 2018-11-16 | 贵州江口骆象茶业有限公司 | A kind of function tea for preventing and treating hypertension |
| CN109965050A (en) * | 2019-04-30 | 2019-07-05 | 遵义医科大学 | A kind of natural red health care green tea beverage |
-
2003
- 2003-05-08 CN CNA031285449A patent/CN1547965A/en active Pending
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1921929A4 (en) * | 2005-08-12 | 2009-08-05 | Multi Formulations Ltd | Supplemental dietary composition including caffeine, taurine and ginseng |
| CN101095551B (en) * | 2007-07-19 | 2010-12-01 | 钟旭 | Method for preparing health-care carbonic acid beverage |
| CN101653184B (en) * | 2009-08-25 | 2012-02-22 | 广州市凯虹香精香料有限公司 | Acid inflatable cool-tea drink |
| CN102885149A (en) * | 2012-10-30 | 2013-01-23 | 陈志冲 | Health-care milk tea and preparation method thereof |
| CN103518878A (en) * | 2013-09-26 | 2014-01-22 | 朱奕 | Honey vinegar beverage with function of lubricating intestines and invigorating stomach and preparation method thereof |
| CN104171156A (en) * | 2014-08-25 | 2014-12-03 | 黄家亨 | Rice vinegar tea beverage capable of clearing away heat and toxic materials and preparation method thereof |
| CN104522804A (en) * | 2014-12-22 | 2015-04-22 | 广西南宁桂知科技有限公司 | Chrysanthemum tea vinegar beverage and preparation method thereof |
| CN105707595A (en) * | 2016-02-02 | 2016-06-29 | 田家丰 | Beverage capable of preventing and treating computer xeroma and preparation method of beverage |
| CN105876558A (en) * | 2016-06-25 | 2016-08-24 | 张阳康 | Healthcare beverage and production process thereof |
| CN108813001A (en) * | 2018-05-25 | 2018-11-16 | 贵州江口骆象茶业有限公司 | A kind of function tea for preventing and treating hypertension |
| CN109965050A (en) * | 2019-04-30 | 2019-07-05 | 遵义医科大学 | A kind of natural red health care green tea beverage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1223283C (en) | Phycomycetes food for improving physical ability of athletes and its preparation method | |
| CN101619284B (en) | Selenium-enriched health care germ-retaining rice pear vinegar and production method thereof | |
| CN1799429A (en) | Beverage with bamboo and siberian solomoseal rhizome its preparation method | |
| CN103710237B (en) | A kind of bee wine and preparation method thereof | |
| CN1547965A (en) | Tea beverage and its prepn | |
| CN1292683C (en) | Solid beverage capable of balancing diet nutrition | |
| CN1223668C (en) | Method for producing Chinese wolfberry liquor | |
| CN106173743A (en) | A kind of preparation method of fermented asparagus beverage | |
| CN103497867B (en) | Mango banana fruit wine and production method thereof | |
| CN1256124C (en) | Blood-supplementing medicine composition | |
| CN1135843A (en) | Ginseng tea | |
| CN106901116A (en) | A kind of fermentation process of Amorphophallus rivieri beverage | |
| CN1007357B (en) | Production of fermented honey wines | |
| CN105475855B (en) | High microsteping mung bean protein peptide composite nutrient food and its Green production method | |
| CN112088995A (en) | Preparation method of rosa roxburghii tratt composite beverage | |
| CN107897588A (en) | Black ginseng garlic drinks and preparation method thereof | |
| CN107173788A (en) | A kind of medlar chilli sauce without any additive and preparation method thereof | |
| CN1108162C (en) | Men's tonic wine and its preparation | |
| CN1466990A (en) | Health food for protecting liver and adjusting blood fat and method for preparing the same | |
| KR100856567B1 (en) | Method for make of Health Supplement Food containing Wild Ginseng root cultivated powder | |
| CN1717243A (en) | Papaya puree and the use of the same | |
| CN108514123A (en) | The active peptides extracted from blood clam prepare compound method | |
| CN109497228A (en) | A kind of brown sugar ginger tea and preparation method thereof | |
| CN104673577A (en) | SOD wine and preparation method thereof | |
| CN110063437A (en) | A kind of Siraitia grosvenorii banana mango pulp juice and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |